Ranbaxy’s Goa plant gets MHRA, UK approval Ranbaxy Laboratories (RL) announced that the company has received approval from Medicines and Healthcare products Regulatory Agency (MHRA), UK, for its Goa-based dosage forms manufacturing facility.
News Briefs
Velcade for multiple myeloma approved in India
The Indian regulatory authorities have given permission for import of Velcade (bortezomib), a new line of treatment for multiple myeloma, a devastating cancer of the blood, bringing new hope to those suffering from the disease.